SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

HCW Biologics Inc. Common Stock

HCWB XNAS
$0.75 +0.01 (+1.90%) ▲ 15-min delayed
Open
$0.72
High
$0.80
Low
$0.70
Volume
23.6K
Market Cap
$1.64M

About HCW Biologics Inc. Common Stock

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 35 Website →

Get HCWB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on HCW Biologics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.